home / stock / cansf / cansf news


CANSF News and Press, Makena Resources Inc

Stock Information

Company Name: Makena Resources Inc
Stock Symbol: CANSF
Market: OTC
Website: willowbio.com

Menu

CANSF CANSF Quote CANSF Short CANSF News CANSF Articles CANSF Message Board
Get CANSF Alerts

News, Short Squeeze, Breakout and More Instantly...

CANSF - WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM

WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM Canada NewsWire Company announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients Company anticipates ...

CANSF - Willow Bioscience Announces 3 Million dollar Fundraising to Support Partnership with Laurus Labs

(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share the company's plans to raise approximately $3 million. This capital will be used to support Willow Bioscience's recent partnership announcement with Laurus Labs. Dr. Savile explained that t...

CANSF - WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION

WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / SUNNYVALE, Calif. , June 3, 2024 /CNW/ - Willow Bioscienc...

CANSF - WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS

WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS Canada NewsWire Collaboration provides Laurus access to Willow's AI-driven bioengineering platform The strategic alliance includes ...

CANSF - Willow Biosciences reports Q1 results; reaffirms FY24 outlook

2024-05-13 09:22:17 ET More on Willow Biosciences: Financial information for Willow Biosciences Inc. Read the full article on Seeking Alpha For further details see: Willow Biosciences reports Q1 results; reaffirms FY24 outlook

CANSF - WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Canada NewsWire Company continues to advance its corticosteroid production platform and anticipates signing a large strategic partnership in Q2 2024 Signed two new program agr...

CANSF - Willow Biosciences GAAP EPS of -C$0.10, revenue of C$1.17M

2024-03-29 09:10:30 ET More on Willow Biosciences Financial information for Willow Biosciences Read the full article on Seeking Alpha For further details see: Willow Biosciences GAAP EPS of -C$0.10, revenue of C$1.17M

CANSF - WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF Canada NewsWire Completed the reorganization of the Company during 2023 with all lab operations now located in the Sunnyvale, California Record...

CANSF - WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC

WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC Canada NewsWire CALGARY, AB , Feb. 29, 2024 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Company ") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology c...

CANSF - WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS

WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS Canada NewsWire Investment further validates Willow's technology for the development and sustainable manufacture of natural ingredients Additional capital will ...

Next 10